Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oil spill and Omega Protein

This article was originally published in The Tan Sheet

Executive Summary

The oil leak in the Gulf of Mexico following the explosion of the Deepwater Horizon rig forces Omega Protein to shift fishing operations away from its Moss Point, Miss., facility. CEO Joe von Rosenberg said May 10 he does not expect a negative affect on fish catch or product quality. On May 6, Omega Protein reported a 7 percent increase in revenue to $32.3 million in the first-quarter. Higher fish meal pricing was offset by decreased fish oil pricing, reflecting contracts initiated in 2008, the peak of the fish oil sales market, the omega-3 ingredient firm said. Net income during the three months ended March 31 dropped 53.4 percent to $979,000. The year-ago quarter included $2.7 million from a hurricane assistance grant

You may also be interested in...

Yes For Shionogi But No For Lilly In Latest EMA Recommendations

The European Medicines Agency says that Shionogi’s novel antibiotic, Fetcroja, should be approved for use across Europe but that Lilly's migraine drug, Emgality, should not be authorized for the extended indication of episodic cluster headache.

UK To Seek Only Limited Regulatory Alignment With EU

Despite the life sciences industry’s call for continued alignment of medicines regulation with the EU from next year and for some sort of co-operation with the European Medicines Agency, it seems the UK government is prepared to make only small concessions.

Pipeline Watch: Clinical Trial Starts In COVID-19

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts